Paroxetine for the prevention of depression induced by high-dose interferon alfa

Dominique L. Musselman, David H. Lawson, Jane F. Gumnick, Amita K. Manatunga, Suzanne Penna, Rebecca S. Goodkin, Kristen Greiner, Charles B. Nemeroff, Andrew H. Miller

Research output: Contribution to journalArticle

867 Scopus citations

Abstract

Background Depression commonly complicates treatment with the cytokine interferon alfa-2b. Laboratory animals pretreated with antidepressants have less severe depression-like symptoms after the administration of a cytokine. We sought to determine whether a similar strategy would be effective in humans. Methods In a double-blind study of 40 patients with malignant melanoma who were eligible for high-dose interferon alfa therapy, we randomly assigned 20 patients to receive the antidepressant paroxetine and 20 to receive placebo. The treatment was begun 2 weeks before the initiation of interferon alfa and continued for the first 12 weeks of interferon alfa therapy. Results During the first 12 weeks of interferon alfa therapy, symptoms consistent with a diagnosis of major depression developed in 2 of 18 patients in the paroxetine group (11 percent) and 9 of 20 patients in the placebo group (45 percent) (relative risk, 0.24; 95 percent confidence interval, 0.08 to 0.93). Severe depression necessitated the discontinuation of interferon alfa before 12 weeks in 1 of the 20 patients in the paroxetine group (5 percent), as compared with 7 patients in the placebo group (35 percent) (relative risk, 0.14; 95 percent confidence interval, 0.05 to 0.85). The incidence of adverse events was similar in the two groups. Conclusions In patients with malignant melanoma, pretreatment with paroxetine appears to be an effective strategy for minimizing depression induced by interferon alfa.

Original languageEnglish (US)
Pages (from-to)961-966
Number of pages6
JournalNew England Journal of Medicine
Volume344
Issue number13
DOIs
StatePublished - Mar 29 2001
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Paroxetine for the prevention of depression induced by high-dose interferon alfa'. Together they form a unique fingerprint.

  • Cite this

    Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001). Paroxetine for the prevention of depression induced by high-dose interferon alfa. New England Journal of Medicine, 344(13), 961-966. https://doi.org/10.1056/NEJM200103293441303